Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 07 - 09    symbols : Bmy    save search

Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published: 2021-07-09 (Crawled : 18:17) - fda.gov
REGN | $896.27 0.26% 0.25% 500K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
INCY | $52.3 -0.98% -0.99% 2.2M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
CLVS | $0.0812 -3.94% twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
KPTI | $1.16 -9.38% -10.34% 1.4M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BMY | $48.93 1.3% 0.0% 10M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ADCT | $4.72 -0.84% 0.0% 320K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
YMAB | $15.15 1.0% 0.99% 470K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BPMC | $86.87 -2.28% -2.34% 800K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
EPZM | $1.47 -1.34% 0.0% twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
AVEO | $15.0 0.0% 0 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

cancer approval
Oncology Therapeutics Market to exceed US$ 247.5 Billion by 2027 Globally |CAGR: 8.2%| UnivDatos Market Insights
Published: 2021-07-09 (Crawled : 15:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.89% C: 0.69%
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.0% C: 0.0%
BMY | $48.93 1.3% 0.0% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.01% H: 1.3% C: 0.69%
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 1.17% C: 0.87%

market
Global Colorectal Cancer Drugs Markets Report 2021-2030: VEGF Inhibitors, EGFR Inhibitors, BRAF or MEK Inhibitors, TKI Inhibitors, Immunomodulators, PD1/PDL1 Inhibitors
Published: 2021-07-09 (Crawled : 11:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M twitter stocktwits trandingview |
Health Technology
| | O: 0.71% H: 1.44% C: 0.2%
BMY | $48.93 1.3% 0.0% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.01% H: 1.3% C: 0.69%
ABT | News | $107.28 1.91% 0.18% 10M twitter stocktwits trandingview |
Health Technology
| | O: 0.31% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.0% H: 0.0% C: 0.0%

cancer colorectal cancer drug
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.